Detalhe da pesquisa
1.
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.
Proc Natl Acad Sci U S A
; 118(37)2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508005
2.
Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer.
Mol Cell Biochem
; 476(6): 2295-2306, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33582945
3.
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111 In]In-XYIMSR-01 for phase I regulatory approval.
J Labelled Comp Radiopharm
; 64(6): 243-250, 2021 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576099
4.
Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization.
Int J Mol Sci
; 21(18)2020 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32932591
5.
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide.
Mol Imaging
; 18: 1536012119852189, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31187691
6.
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.
Eur J Nucl Med Mol Imaging
; 46(12): 2545-2557, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399803
7.
PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration.
Eur J Nucl Med Mol Imaging
; 46(9): 1940-1951, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161257
8.
MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.
Mol Pharm
; 16(5): 2060-2068, 2019 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912947
9.
Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer.
Mol Pharm
; 16(6): 2590-2604, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002252
10.
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.
Chemistry
; 24(28): 7235-7242, 2018 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508450
11.
Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer.
Mol Pharm
; 15(9): 3946-3952, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30037229
12.
Rapid PD-L1 detection in tumors with PET using a highly specific peptide.
Biochem Biophys Res Commun
; 483(1): 258-263, 2017 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025143
13.
PD-L1 Detection in Tumors Using [(64)Cu]Atezolizumab with PET.
Bioconjug Chem
; 27(9): 2103-10, 2016 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458027
14.
Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
Bioconjug Chem
; 27(6): 1447-55, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27076393
15.
[(18)F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance.
Bioconjug Chem
; 27(7): 1655-62, 2016 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270097
16.
Structural characterization and in vivo evaluation of ß-Hairpin peptidomimetics as specific CXCR4 imaging agents.
Mol Pharm
; 12(3): 941-53, 2015 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25590535
17.
Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.
Angew Chem Int Ed Engl
; 54(37): 10778-82, 2015 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26212031
18.
Imaging Axl expression in pancreatic and prostate cancer xenografts.
Biochem Biophys Res Commun
; 443(2): 635-40, 2014 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24333418
19.
Heterobivalent agents targeting PSMA and integrin-αvß3.
Bioconjug Chem
; 25(2): 393-405, 2014 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24410012
20.
Corrigendum to "Rapid PD-L1 detection in tumors with PET using a highly specific peptide" [Biochemical and Biophysical Research Communications 483/1 (2017) 258-263].
Biochem Biophys Res Commun
; 491(4): 1125, 2017 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801167